CA2501958A1 - Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001 - Google Patents

Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001 Download PDF

Info

Publication number
CA2501958A1
CA2501958A1 CA002501958A CA2501958A CA2501958A1 CA 2501958 A1 CA2501958 A1 CA 2501958A1 CA 002501958 A CA002501958 A CA 002501958A CA 2501958 A CA2501958 A CA 2501958A CA 2501958 A1 CA2501958 A1 CA 2501958A1
Authority
CA
Canada
Prior art keywords
ltered
genetic
seq
polynucleotide
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002501958A
Other languages
English (en)
French (fr)
Inventor
Matthew Glenn
Ikka J. Havukkala
Mark William Lubbers
James Dekker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Genesis Research and Development Corp Ltd
Fonterra Cooperative Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Research and Development Corp Ltd, Fonterra Cooperative Group Ltd filed Critical Genesis Research and Development Corp Ltd
Publication of CA2501958A1 publication Critical patent/CA2501958A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/032Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C2220/00Biochemical treatment
    • A23C2220/20Treatment with microorganisms
    • A23C2220/202Genetic engineering of microorganisms used in dairy technology
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002501958A 2002-10-03 2003-10-03 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001 Abandoned CA2501958A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/264,213 US7125698B2 (en) 1999-08-09 2002-10-03 Polynucleotides, materials incorporating them, and methods for using them
US10/264,213 2002-10-03
PCT/NZ2003/000221 WO2004031389A1 (en) 2002-10-03 2003-10-03 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001

Publications (1)

Publication Number Publication Date
CA2501958A1 true CA2501958A1 (en) 2004-04-15

Family

ID=32068293

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002501958A Abandoned CA2501958A1 (en) 2002-10-03 2003-10-03 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001

Country Status (6)

Country Link
US (1) US7125698B2 (enExample)
EP (1) EP1546338A4 (enExample)
JP (1) JP2006500951A (enExample)
AU (1) AU2003278624A1 (enExample)
CA (1) CA2501958A1 (enExample)
WO (1) WO2004031389A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
EP1658303A4 (en) * 2003-04-25 2008-07-16 Univ North Carolina State LACTOBACILLUS ACIDOPHILUS NUCLEIC ACID CODING FOR CELL SURFACE PROTEIN HOMOLOGOUS
US7407787B2 (en) * 2003-06-23 2008-08-05 North Carolina State University Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
US7455992B2 (en) 2004-02-23 2008-11-25 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefore
US7459289B2 (en) * 2004-03-08 2008-12-02 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
US7608700B2 (en) * 2004-03-08 2009-10-27 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
US7550576B2 (en) 2004-08-09 2009-06-23 North Carolina State University Nucleic acid sequences encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor
US7468182B2 (en) * 2004-10-27 2008-12-23 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
US7495092B2 (en) * 2005-01-14 2009-02-24 North Carolina State University Compositions comprising promoter sequences and methods of use
TW200700074A (en) 2005-03-04 2007-01-01 Calpis Co Ltd Inducer of t cell apoptosis
EP2123291B1 (en) 2006-12-21 2012-05-30 Calpis Co., Ltd. Use of Lactobacillus amylovorus for treating periodontal diseases by stimulating IgA production
AU2009249180A1 (en) * 2008-05-19 2009-11-26 Burnham Institute For Medical Research Intestinal Alkaline Phosphatase modulators and uses thereof
US8445426B2 (en) * 2009-02-02 2013-05-21 Valio Ltd. Peptides and methods for producing them
CA2750576C (en) * 2009-02-02 2019-02-26 Willem Meindert De Vos Novel pilus polypeptides
BR112012017978A2 (pt) 2010-01-19 2016-05-03 Abbott Lab fórmulas nutricionais contendo simbióticos
CN102770527B (zh) 2010-01-28 2016-01-20 科·汉森有限公司 基于噬菌体抗性选择的用于对食品进行质构化的乳酸细菌
UA113279C2 (xx) * 2010-10-22 2017-01-10 Спосіб забезпечення текстурувального штаму молочнокислих бактерій, його застосування і композиція на його основі
WO2013101516A1 (en) 2011-12-29 2013-07-04 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna
EP2841590A4 (en) * 2012-04-27 2016-03-23 Pronutria Inc NUCLEIC ACIDS, CELLS, AND METHOD FOR PRODUCING SECRETATED PROTEINS
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN108330162B (zh) * 2017-05-26 2021-07-06 红河学院 一种利用SCoT分子标记分析草果遗传多样性的方法
CN109735556A (zh) * 2019-02-22 2019-05-10 昆明理工大学 引导糖基转移酶基因的用途
CN113832067B (zh) * 2021-10-14 2023-12-08 吉林农业大学 一种常温菌低温生长促进剂及其制备和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228046B1 (en) * 1997-08-21 2013-03-28 New Zealand Dairy Board Immunity enhancing lactic acid bacteria
US6544772B1 (en) 2000-08-08 2003-04-08 Genesis Research & Development Corp. Ltd Polynucleotides, materials incorporating them, and methods for using them
US6476209B1 (en) * 2000-11-28 2002-11-05 Genesis Research & Development Corporation Ltd. Polynucleotides, materials incorporating them, and methods for using them
US7026463B2 (en) * 1999-08-13 2006-04-11 Matthew Glenn Polynucleotides and polypeptides, materials incorporating them and methods for using them
DE60128742T2 (de) * 2000-03-03 2008-02-07 Fujifilm Manufacturing Europe B.V. Verfahren zur Herstellung polymerlaminierter Papierträger und durch dieses Verfahren hergestellte polymerlaminierte photographische Papierträger
US20020061569A1 (en) * 2000-03-21 2002-05-23 Robert Haselbeck Identification of essential genes in prokaryotes
WO2001077335A2 (fr) 2000-04-11 2001-10-18 Institut Pasteur Genome de listeria monocytogenes, polypeptides et utilisations
CA2416982A1 (en) * 2000-08-08 2002-02-14 Genesis Research And Development Corporation Limited Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them

Also Published As

Publication number Publication date
US7125698B2 (en) 2006-10-24
WO2004031389A1 (en) 2004-04-15
JP2006500951A (ja) 2006-01-12
US20040009490A1 (en) 2004-01-15
EP1546338A4 (en) 2006-03-22
AU2003278624A1 (en) 2004-04-23
EP1546338A1 (en) 2005-06-29

Similar Documents

Publication Publication Date Title
US7125698B2 (en) Polynucleotides, materials incorporating them, and methods for using them
CN1774447B (zh) 肺炎链球菌抗原
Henneke et al. Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis
US6476209B1 (en) Polynucleotides, materials incorporating them, and methods for using them
US7052896B2 (en) Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
US20220127628A1 (en) A genetically modified lactobacillus and uses thereof
DK2391641T3 (en) Lactobacillus rhamnosus pili og pilus polypeptider
AU2001284558A1 (en) Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
US6544772B1 (en) Polynucleotides, materials incorporating them, and methods for using them
US7026463B2 (en) Polynucleotides and polypeptides, materials incorporating them and methods for using them
ES2678699T3 (es) Queso procesado con componentes lácteos cultivados y método de fabricación
Messner et al. Occurrence, structure, chemistry, genetics, morphogenesis, and functions of S-layers
CA2491847A1 (en) Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination
KR102592424B1 (ko) 병원성 대장균, 살모넬라 또는 시겔라에 대해 사멸능을 갖는 박테리오파지 및 이를 함유하는 항균 조성물
US20050202437A1 (en) Polynucleotides and polypeptides, materials incorporating them and methods for using them
WO2005056801A1 (en) Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
US20060099623A1 (en) Polynucleotides and polypeptides isolated from lactobacillus and methods for their use
Raynor Functional Similarity of PRD-Containing Virulence Regulators in Bacillus anthracis
HK1084958B (en) S. pneumoniae antigens

Legal Events

Date Code Title Description
FZDE Discontinued